Backman named associate director for research technology at Northwestern

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Vadim Backman was named associate director for Research Technology and Infrastructure at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University.

In addition to this new role, Backman, the Walter Dill Scott Professor of Biomedical Engineering at the McCormick School of Engineering and Applied Sciences, will continue to serve as leader of the Cancer and Physical Sciences Program at the Lurie Cancer Center.

As associate director, Backman will oversee Lurie Cancer Center’s infrastructure for interdisciplinary programs and initiatives, which include the center’s 16 Shared Resources that foster basic, clinical and translational research. He will also lead the development of innovative tools, technologies and services to support emerging disciplines across the cancer center.

Backman succeeds Milan Mrksich, the Henry Wade Rogers Professor, who was recently named Northwestern University’s interim vice president for research.

An expert in biomedical optics, Backman has developed numerous imaging technologies. Through his nanocytology technique, he developed a simple, easy-to-use test for diagnosing multiple forms of cancer at the earliest stage of disease formation. He leads Northwestern’s new Center for Physical Genomics and Engineering, focused on the entirely new field using optical imaging and computational genomics to reprogram the genome’s chromatin, which regulates gene expression.

Table of Contents

YOU MAY BE INTERESTED IN

In this episode of The Cancer Letter Podcast, Fran Visco, president of the National Breast Cancer Coalition, and Jacquelyn Cobb, managing editor of The Cancer Letter, discuss the Metastatic Breast Cancer Act, bipartisan legislation that would eliminate the waiting periods for Social Security Disability Insurance and Medicare for eligible people with metastatic breast cancer. 
Congress settled the FY26 question in February, with NCI receiving $7.352 billion, an increase of $128 million over the prior year. After a year in which cancer center directors spent an extraordinary share of their leadership attention defending the research enterprise, that outcome deserves to be called what it was: a win.
Harold P. Freeman, a surgeon who started his career in Harlem, where, in addition to performing surgeries, he pioneered the system of patient navigation, and who studied health disparities and served as president of the American Cancer Society and chair of the President’s Cancer Panel, died on Aug. 11. He was 93.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login